MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emergent Biosolutions (NY: EBS )

7.720 -1.550 (-16.72%)
Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Other Filings

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Form S-8
Source: SEC/Edgar
May 29, 2018
Form 8-K
Source: SEC/Edgar
May 23, 2018
Form 8-K
Source: SEC/Edgar
May 02, 2018
Form DEFA14A
Source: SEC/Edgar
April 12, 2018
Form DEF 14A
Source: SEC/Edgar
April 12, 2018
Form CT ORDER
Source: SEC/Edgar
April 02, 2018
Form 8-K
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 08, 2018
Form SC 13G/A
Source: SEC/Edgar
February 08, 2018
Form SC 13G/A
Source: SEC/Edgar
January 22, 2018
Form 8-K
Source: SEC/Edgar
January 15, 2018
Form 8-K
Source: SEC/Edgar
January 07, 2018
Form CT ORDER
Source: SEC/Edgar
December 06, 2017
Form 8-K
Source: SEC/Edgar
November 13, 2017
Form 8-K
Source: SEC/Edgar
October 05, 2017
Form 8-K
Source: SEC/Edgar
October 02, 2017
Form 8-K
Source: SEC/Edgar
October 01, 2017
Form CT ORDER
Source: SEC/Edgar
August 13, 2017
Form CT ORDER
Source: SEC/Edgar
August 13, 2017
Form 8-K
Source: SEC/Edgar
August 02, 2017
Form 8-K
Source: SEC/Edgar
July 24, 2017
Form 8-K
Source: SEC/Edgar
July 13, 2017
Form CT ORDER
Source: SEC/Edgar
May 14, 2017
Form DEF 14A
Source: SEC/Edgar
April 12, 2017
Form DEFA14A
Source: SEC/Edgar
April 12, 2017
Form SC 13G/A
Source: SEC/Edgar
April 09, 2017
Form 8-K
Source: SEC/Edgar
March 16, 2017
Form 8-K
Source: SEC/Edgar
February 22, 2017
Form 8-K
Source: SEC/Edgar
February 20, 2017
Form CT ORDER
Source: SEC/Edgar
February 13, 2017
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story